Press Releases

GlobeNewswire, Inc.

Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients.

EIN Presswire

Featuring senior industry voices, the issue explores cross-border investment, financial innovation and the growing importance of trust in global markets.

GlobeNewswire, Inc.

First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to anticipated inventory drawdowns and...

GlobeNewswire, Inc.

Link to Week 43 Article: https://thinkcarebelieve.blog/2025/11/15/week-43-the-reopening-of-america/ WASHINGTON, Nov. 15, 2025 (GLOBE NEWSWIRE) -- ThinkCareBelieve has published an article on Week 43 on the Reopening of America under the leadership...

GlobeNewswire, Inc.

LONDON, May 06, 2026 (GLOBE NEWSWIRE) -- Clear Street ("Clear Street" or "the Company"), a cloud-native financial infrastructure technology firm on a mission to give sophisticated investors access to every asset in every market, through a unified...

GlobeNewswire, Inc.

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 04, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...

GlobeNewswire, Inc.

License Marks the Latest Step in Clear Street's Global Expansion Plan Strengthens Growing European Presence Alongside its Established U.K. Operations NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Clear Street ("Clear Street" or "the Company"), a...

GlobeNewswire, Inc.

• Investment to accelerate expansion in North America and enhance product offering • Values MillTech at $325m • MillTech reports c.$500bn annual trading volume, $35bn in client programmes and 70%+ revenue growth LONDON, April 09, 2026 (GLOBE...

GlobeNewswire, Inc.

If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on Phase II/III clinical data...

GlobeNewswire, Inc.

OilXCoin Launches Secondary Market Trading and Acquires O&G Lease in Kansas, USA Trading commences on Archax and Assetera, marking a major milestone in bringing the world’s most traded commodity on-chain.

EIN Presswire

The Winter 2026 edition of The European is out now. Order your print or digital copy for exclusive interviews, expert analysis and global insights.

EIN Presswire

AI is reshaping democracy faster than rules can follow.

GlobeNewswire, Inc.

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ARS Pharma’s partner, ALK-Abelló A/S, who owns the rights to market EURneffy in the EU, will distribute following expected...

EIN Presswire

DAVOS, SWITZERLAND, January 28, 2026 /⁨EINPresswire.com⁩/ -- On January 22, 2026, the American Swiss Foundation (ASF) co-hosted the “Swiss-American Friendship Cocktail” reception during the 2026 World Economic Forum Annual Meeting alongside the...

EIN Presswire

update on the year 2025 which has been a decisive period for bonyf, marked by regulatory achievements, sustained innovation and accelerating commercial momentum bonyf NV (ENX:MLBON) KNOKKE-HEIST, KNOKKE-HEIST, BELGIUM, January 28, 2026...

GlobeNewswire, Inc.

Geneva, Switzerland, Jan. 05, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today...

GlobeNewswire, Inc.

REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and...

GlobeNewswire, Inc.

According to the settlement agreement, the proposed biosimilar to Eylea® (aflibercept) can be marketed in the U.S., if approved by the FDA, in the fourth quarter of 2026, or earlier under certain circumstances REYKJAVIK, Iceland and TEL AVIV,...

EIN Presswire

BERN, SWITZERLAND, December 11, 2025 /⁨EINPresswire.com⁩/ -- On November 12th, the American Swiss Foundation hosted its annual Alumni Dinner in Bern, bringing together more than 200 alumni, leaders, and guests from across Switzerland and the...

EIN Presswire

The Business Research Company's Forestry Software Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, December 5, 2025 /⁨EINPresswire.com⁩/ -- The Forestry Software market is...